Clinical Developmentstudy News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Clinical Developmentstudy. Real-time updates on events, politics, business and more.

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

March 23, 2022

Researchers evaluate antiviral effects of CD63 tetraspanin extracellular vesicles against SARS-CoV-2 and HIV-1.

Source: news-medical.net